Stay updated on Intranasal Vasopressin in Autism Children Clinical Trial
Sign up to get notified when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.

Latest updates to the Intranasal Vasopressin in Autism Children Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe NIH banner announcing website-transition updates and the temporary use of “Super Intelligence” terminology was removed. The page continues to display a 403 Forbidden error.SummaryDifference1%

- Check14 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden message instead of the study record.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces that NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access is blocked to the study record on ClinicalTrials.gov. It no longer shows the usual study details.SummaryDifference0.5%

Stay in the know with updates to Intranasal Vasopressin in Autism Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.